top of page

Inherited Disease Testing

INTROL® Control Panel

  • Cystic Fibrosis Panel I Control

  • Cystic Fibrosis Panel II Control

  • Cystic Fibrosis Panel III Control

  • Cystic Fibrosis Panel I Control v.02

  • Hereditary Hemochromatosis Panel I Control

  • Hereditary Hemochromatosis Panel II Control

  • Thrombosis Genotype Panel

  • Thrombotic Risk Genotype Control

 

GeneXpert Control Panel

  • Xpert FII & FV Genotype Panel G109

  • Xpert FII & FV HET

  • Xpert FII & FV NOR/MUT Control

​​

NGS CF Control Panel G211 v1.1​​

MMQCI-vector-logo-2.png
  • Blood Borne Viruses
    Hepatitis A Virus (HAV) Hepatitis E Virus (HEV) Parvovirus B19
  • Enteric Viruses and Bacteria
    Clostridium difficile EHEC Norovirus Rotavirus
  • Human Adenovirus, Human Herpesvirus and Polyomavirus
    Human adenovirus (ADV) Cytomegalovirus (CMV) Epstein-Barr Virus (EBV) Human Herpesvirus 6A and 6B (HHV-6) Herpes Simplex Virus 1 and 2 (HSV) Varicella-Zoster Virus (VZV) BK Virus (BKV) JC Virus (JCV)
  • Respiratory Viruses, Bacteria and Fungi
    Human adenovirus (ADV) Enterovirus (ENV) and Rhinovirus (RHV) Human Influenza A and B and SwineFlu Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Human Metapneumovirus A and B (hMPV) Human Parainfluenza Virus 1– 4 (PIV) Respiratory Syncytial Virus A and B (RSVA and RSVB) Bordetella pertussis and Bordetella parapertussis Pneumocystis jirovecii
  • Tropical and other Viruses, Bacteria and Parasites
    AHFV/KFDV CCHFV Chagas Chikungunya Dengue Ebolavirus Filovirus Lassa Virus Malaria Rift Valley Fever Trichomonas vaginalis WNV Yellow Fever Zika Virus
M320v1_1.jpg

The cGMP-grade controls comprise  of synthetic DNA/RNA suspension in non-infectious solution of buffers, preservatives and stabilizers, are made to mimic clinical specimens under laboratory conditions. Intended for in-vitro use as an external control to monitor the nucleic acid detection of genetic markers causing inherited diseases.

​

❮ BACK TO MMQCI MAIN

Inherited Disease Testing

Infectious Disease Testing

  • ePlex Control Panel

  • BCID-FP Control M320 v1.1

  • BCID-GP Control M323 v1.1

  • BCID-GN Control M326

  • RP Control M306

  • RP2 Control M451

  • SARS-CoV-2 Control Panel M435

BioFire / FilmArray® Control Panel

  • RP Control Panel M210 v1.1

  • RP EZ Control Panel M265

  • RP2.1/RP2.1plus Control Panel M441

  • BCID Control Panel M235 v1.1

  • BCID2 Control Panel M416

  • GI Control Panel M238

  • Ebola Control Panel M251

  • Pneumonia/Pneumoniaplus Control M340

  • JI Control Panel M420

GeneXpert Control Panel

  • Carba-R QC Panel M219RP EZ Control Panel M265

  • SARS-CoV-2 Control Panel M430

INTROL® Control Panel

  • ME Control Panel M262

  • TB Panel M110

  • TB Panel M114

  • TB Panel M114plus

  • TB-XDR Panel M345

  • TBNEG-30

Unyvero LRT Control Panel

  • LRT/Pneumonia Control Panel M404

  • LRT Verification Panel M408

eSensor® XT-8™ RVP Control Panel

QIAstat-Dx RP SARS-CoV-2 Control Panel

Verigene® RP Flex Control Panel M270el

The cGMP-grade controls comprise  of synthetic DNA/RNA suspension in non-infectious solution of buffers, preservatives and stabilizers, are made to mimic clinical specimens under laboratory conditions. Intended for in-vitro use as an external control to monitor the nucleic acid detection of causative pathogens in infectious diseases.
 

❮ BACK TO MMQCI MAIN

Infectious Disease Testing
  • Blood Borne Viruses
    Hepatitis A Virus (HAV) Hepatitis E Virus (HEV) Parvovirus B19
  • Enteric Viruses and Bacteria
    Clostridium difficile EHEC Norovirus Rotavirus
  • Human Adenovirus, Human Herpesvirus and Polyomavirus
    Human adenovirus (ADV) Cytomegalovirus (CMV) Epstein-Barr Virus (EBV) Human Herpesvirus 6A and 6B (HHV-6) Herpes Simplex Virus 1 and 2 (HSV) Varicella-Zoster Virus (VZV) BK Virus (BKV) JC Virus (JCV)
  • Respiratory Viruses, Bacteria and Fungi
    Human adenovirus (ADV) Enterovirus (ENV) and Rhinovirus (RHV) Human Influenza A and B and SwineFlu Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Human Metapneumovirus A and B (hMPV) Human Parainfluenza Virus 1– 4 (PIV) Respiratory Syncytial Virus A and B (RSVA and RSVB) Bordetella pertussis and Bordetella parapertussis Pneumocystis jirovecii
  • Tropical and other Viruses, Bacteria and Parasites
    AHFV/KFDV CCHFV Chagas Chikungunya Dengue Ebolavirus Filovirus Lassa Virus Malaria Rift Valley Fever Trichomonas vaginalis WNV Yellow Fever Zika Virus
M441.jpg

Oncology Testing

  • GeneXpert Control Panel

  • BCR-ABL IS Panel C130

  • BCR-ABL 0%IS

  • Bladder Cancer Panel C104

  • INTROL® BCR-ABL1 p190 Control Panel

  • Blood Borne Viruses
    Hepatitis A Virus (HAV) Hepatitis E Virus (HEV) Parvovirus B19
  • Enteric Viruses and Bacteria
    Clostridium difficile EHEC Norovirus Rotavirus
  • Human Adenovirus, Human Herpesvirus and Polyomavirus
    Human adenovirus (ADV) Cytomegalovirus (CMV) Epstein-Barr Virus (EBV) Human Herpesvirus 6A and 6B (HHV-6) Herpes Simplex Virus 1 and 2 (HSV) Varicella-Zoster Virus (VZV) BK Virus (BKV) JC Virus (JCV)
  • Respiratory Viruses, Bacteria and Fungi
    Human adenovirus (ADV) Enterovirus (ENV) and Rhinovirus (RHV) Human Influenza A and B and SwineFlu Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Human Metapneumovirus A and B (hMPV) Human Parainfluenza Virus 1– 4 (PIV) Respiratory Syncytial Virus A and B (RSVA and RSVB) Bordetella pertussis and Bordetella parapertussis Pneumocystis jirovecii
  • Tropical and other Viruses, Bacteria and Parasites
    AHFV/KFDV CCHFV Chagas Chikungunya Dengue Ebolavirus Filovirus Lassa Virus Malaria Rift Valley Fever Trichomonas vaginalis WNV Yellow Fever Zika Virus
C130.jpg

The cGMP-grade controls comprise  of synthetic DNA/RNA suspension in non-infectious solution of buffers, preservatives and stabilizers, are made to mimic clinical specimens under laboratory conditions. Intended for in-vitro use as an external control to monitor the nucleic acid detection of genetic markers in oncology testing.
 

❮ BACK TO MMQCI MAIN

Oncology Testing

Pharmacogenomics Testing

  • INTROL® Control Panel

  • 2C19 Panel P105

  • 2C19 Panel P110

  • PGx 1 Control

The cGMP-grade controls comprise  of synthetic DNA/RNA suspension in non-infectious solution of buffers, preservatives and stabilizers, are made to mimic clinical specimens under laboratory conditions. Intended for in-vitro use as an external control to monitor the nucleic acid detection of genetic markers in pharmacogenomic testing.
  

❮ BACK TO MMQCI MAIN

Pharmacogenomics Testing
  • Blood Borne Viruses
    Hepatitis A Virus (HAV) Hepatitis E Virus (HEV) Parvovirus B19
  • Enteric Viruses and Bacteria
    Clostridium difficile EHEC Norovirus Rotavirus
  • Human Adenovirus, Human Herpesvirus and Polyomavirus
    Human adenovirus (ADV) Cytomegalovirus (CMV) Epstein-Barr Virus (EBV) Human Herpesvirus 6A and 6B (HHV-6) Herpes Simplex Virus 1 and 2 (HSV) Varicella-Zoster Virus (VZV) BK Virus (BKV) JC Virus (JCV)
  • Respiratory Viruses, Bacteria and Fungi
    Human adenovirus (ADV) Enterovirus (ENV) and Rhinovirus (RHV) Human Influenza A and B and SwineFlu Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Human Metapneumovirus A and B (hMPV) Human Parainfluenza Virus 1– 4 (PIV) Respiratory Syncytial Virus A and B (RSVA and RSVB) Bordetella pertussis and Bordetella parapertussis Pneumocystis jirovecii
  • Tropical and other Viruses, Bacteria and Parasites
    AHFV/KFDV CCHFV Chagas Chikungunya Dengue Ebolavirus Filovirus Lassa Virus Malaria Rift Valley Fever Trichomonas vaginalis WNV Yellow Fever Zika Virus
P105-1.jpg

SARS-CoV-2 Testing

  • BioFire RP2.1/RP2.1plus Control Panel M441

  • QIAstat-Dx RP SARS-CoV-2 Control Panel

  • Xpert SARS-CoV-2 Control Panel M430

  • ePlex Control Panel

  • SARS-CoV-2 Control Panel M435

  • ePlex RP2 Control M451

  • Blood Borne Viruses
    Hepatitis A Virus (HAV) Hepatitis E Virus (HEV) Parvovirus B19
  • Enteric Viruses and Bacteria
    Clostridium difficile EHEC Norovirus Rotavirus
  • Human Adenovirus, Human Herpesvirus and Polyomavirus
    Human adenovirus (ADV) Cytomegalovirus (CMV) Epstein-Barr Virus (EBV) Human Herpesvirus 6A and 6B (HHV-6) Herpes Simplex Virus 1 and 2 (HSV) Varicella-Zoster Virus (VZV) BK Virus (BKV) JC Virus (JCV)
  • Respiratory Viruses, Bacteria and Fungi
    Human adenovirus (ADV) Enterovirus (ENV) and Rhinovirus (RHV) Human Influenza A and B and SwineFlu Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Human Metapneumovirus A and B (hMPV) Human Parainfluenza Virus 1– 4 (PIV) Respiratory Syncytial Virus A and B (RSVA and RSVB) Bordetella pertussis and Bordetella parapertussis Pneumocystis jirovecii
  • Tropical and other Viruses, Bacteria and Parasites
    AHFV/KFDV CCHFV Chagas Chikungunya Dengue Ebolavirus Filovirus Lassa Virus Malaria Rift Valley Fever Trichomonas vaginalis WNV Yellow Fever Zika Virus

The cGMP-grade controls comprise  of synthetic DNA/RNA suspension in non-infectious solution of buffers, preservatives and stabilizers, are made to mimic clinical specimens under laboratory conditions. Intended for in-vitro use as an external control to monitor the nucleic acid detection of SARS-CoV-2 virus.
  

❮ BACK TO MMQCI MAIN

SARS-CoV-2 Testing
M441.jpg
bottom of page